{"id":{"repo_id":"mit","oai_identifier":"oai:dspace.mit.edu:1721.1/146658"},"canonical_url":"https://search.dev.ndltd.org/etd/mit/oai:dspace.mit.edu:1721.1/146658","repository":{"repo_id":"mit","name":"MIT","base_url":"https://dspace.mit.edu/oai/request"},"display":{"title":"Meat No Longer Requires Animal Slaughter – Valuing an Alternative Protein Player","abstract":"Conventional animal protein production faces numerous challenges nowadays. Meanwhile, alternative proteins have been improved significantly over the last years and plant-based proteins are about to reach cost parity. Against this backdrop, foreseeing a rosy future for alternative protein producers and expecting high returns from investing early may seem plausible. Yet there is still considerable uncertainty if and how fast the industry will take off and how profitable the business may become. Valuing Beyond Meat, one of the industry’s leading companies, under multiple scenarios (ranging from pessimistic to very optimistic) can thus shed light not only on whether its valuation but arguably also whether valuations in alternative proteins more broadly are currently overhyped, reasonable, or even offer room for further upside potential. It turns out that the firm’s current share price is a sensible average of Beyond’s potential value in the different scenarios.","abstract_html":"Conventional animal protein production faces numerous challenges nowadays. Meanwhile, alternative proteins have been improved significantly over the last years and plant-based proteins are about to reach cost parity. Against this backdrop, foreseeing a rosy future for alternative protein producers and expecting high returns from investing early may seem plausible. Yet there is still considerable uncertainty if and how fast the industry will take off and how profitable the business may become. Valuing Beyond Meat, one of the industry’s leading companies, under multiple scenarios (ranging from pessimistic to very optimistic) can thus shed light not only on whether its valuation but arguably also whether valuations in alternative proteins more broadly are currently overhyped, reasonable, or even offer room for further upside potential. It turns out that the firm’s current share price is a sensible average of Beyond’s potential value in the different scenarios.","abstract_has_math":false,"creators":["Pagel, Maximilian"],"institution":"Massachusetts Institute of Technology","degree_name":"Master","degree_level":null,"degree_discipline":null,"degree_department":"Sloan School of Management","school":null,"contributors":[],"advisors":["Matveyev, Egor"],"committee_chairs":[],"committee_members":[],"year":2022,"date_issued":"2022-05","date_published":"2022-05","updated_at":"2026-07-22T22:22:19Z","subjects":[],"languages":[],"rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"rights_urls":["https://rightsstatements.org/page/InC-EDU/1.0/"],"identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1721.1/146658","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Matveyev, Egor"]},{"key":"dc:contributor.department","label":"Department","values":["Sloan School of Management"]},{"key":"dc:creator","label":"Author","values":["Pagel, Maximilian"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2022-11-30T19:39:30Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2022-11-30T19:39:30Z"]},{"key":"dc:date.issued","label":"Date","values":["2022-05"]},{"key":"dc:publisher","label":"Institution","values":["Massachusetts Institute of Technology"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master","Master of Science in Management Studies"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:rights","label":"Dc Rights","values":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://rightsstatements.org/page/InC-EDU/1.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1721.1/146658"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Conventional animal protein production faces numerous challenges nowadays. Meanwhile, alternative proteins have been improved significantly over the last years and plant-based proteins are about to reach cost parity. Against this backdrop, foreseeing a rosy future for alternative protein producers and expecting high returns from investing early may seem plausible. Yet there is still considerable uncertainty if and how fast the industry will take off and how profitable the business may become. Valuing Beyond Meat, one of the industry’s leading companies, under multiple scenarios (ranging from pessimistic to very optimistic) can thus shed light not only on whether its valuation but arguably also whether valuations in alternative proteins more broadly are currently overhyped, reasonable, or even offer room for further upside potential. It turns out that the firm’s current share price is a sensible average of Beyond’s potential value in the different scenarios."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["S.M."]},{"key":"dc:title","label":"Title","values":["Meat No Longer Requires Animal Slaughter – Valuing an Alternative Protein Player"]}]}],"canonical_facts":{"dc:contributor.advisor":["Matveyev, Egor"],"dc:contributor.department":["Sloan School of Management"],"dc:creator":["Pagel, Maximilian"],"dc:date.accessioned":["2022-11-30T19:39:30Z"],"dc:date.available":["2022-11-30T19:39:30Z"],"dc:date.issued":["2022-05"],"dc:description.abstract":["Conventional animal protein production faces numerous challenges nowadays. Meanwhile, alternative proteins have been improved significantly over the last years and plant-based proteins are about to reach cost parity. Against this backdrop, foreseeing a rosy future for alternative protein producers and expecting high returns from investing early may seem plausible. Yet there is still considerable uncertainty if and how fast the industry will take off and how profitable the business may become. Valuing Beyond Meat, one of the industry’s leading companies, under multiple scenarios (ranging from pessimistic to very optimistic) can thus shed light not only on whether its valuation but arguably also whether valuations in alternative proteins more broadly are currently overhyped, reasonable, or even offer room for further upside potential. It turns out that the firm’s current share price is a sensible average of Beyond’s potential value in the different scenarios."],"dc:description.degree":["S.M."],"dc:identifier.uri":["https://hdl.handle.net/1721.1/146658"],"dc:publisher":["Massachusetts Institute of Technology"],"dc:rights":["In Copyright - Educational Use Permitted","Copyright retained by author(s)"],"dc:rights.uri":["https://rightsstatements.org/page/InC-EDU/1.0/"],"dc:title":["Meat No Longer Requires Animal Slaughter – Valuing an Alternative Protein Player"],"dc:type":["Thesis"],"thesis:degree_name":["Master","Master of Science in Management Studies"]},"updated_at":"2026-07-22T22:22:19Z"}